Pure Gaze Labs Corp Announces Launch of Innovative Neurological and Vestibular Deficits Detection Lab
- alexkiderman
- Jan 16, 2024
- 2 min read
Pittsburgh, PA, January 16, 2024 – Pure Gaze Labs Corp, a pioneering force in the realm of medical diagnostics, is thrilled to announce the establishment of a state-of-the-art laboratory dedicated to the advancement of neurological and vestibular deficit detection through cutting-edge eye tracking technology. Situated in Pittsburgh, Pennsylvania, this new facility underscores the company’s commitment to leveraging technological innovations to improve diagnostic accuracy and patient care in the neurology and vestibular domains.
The laboratory, under the guidance of esteemed founding president and lab director, Dr. Alex Kiderman, aims to push the boundaries of current medical diagnostic practices. With an impressive track record spanning over three decades in engineering, medical diagnostics, and industrial manufacturing, Dr. Kiderman brings a wealth of experience and insight to the venture. His previous leadership roles at Neurolign and Neuro Kinetics, where he spearheaded numerous concussion and vestibular research initiatives, have been instrumental in securing 26 US-issued patents and contributing to over 20 peer-reviewed publications.
In reflecting on the launch, Dr. Kiderman expressed his enthusiasm: "Embarking on this initiative is a monumental step forward in our quest to transform the landscape of neurological diagnostics. With our team's expertise and the groundbreaking potential of eye tracking technology, I am confident we will unlock new possibilities in detecting and understanding neurological and vestibular deficits. Our mission is to deliver solutions that will significantly enhance patient outcomes and advance the field of neurology."
Pure Gaze Labs’ establishment of this lab is further bolstered by a strategic partnership with Spryson America Inc., a leading entity in healthcare research. This collaboration will see Pure Gaze Labs perform critical research projects on behalf of Spryson America Inc., marrying the expertise and innovative capabilities of both organizations to foster groundbreaking developments in the medical field.
This initiative not only signifies a major leap in diagnostic methodologies but also positions Pure Gaze Labs Corp at the forefront of neurological research and development. Through dedication to innovation and quality, Pure Gaze Labs is set to redefine standards and pave the way for future advancements in the healthcare industry.
About Pure Gaze Labs Corp
Pure Gaze Labs Corp is a leading innovator in medical diagnostic technology, specializing in the development of eye tracking solutions for the detection of neurological and vestibular deficits. Based in Pittsburgh, Pennsylvania, the company is committed to improving diagnostic accuracy and patient care through technological excellence and research. With a focus on pioneering new methodologies and enhancing diagnostic capabilities, Pure Gaze Labs Corp is dedicated to advancing the field of neurology and vestibular sciences.
Contact Information:
Pure Gaze Labs Corp
126 Gamma Drive
Pittsburgh, PA
(412)736-2259
Comments